"Heart Valve Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Descriptor ID |
D006349
|
MeSH Number(s) |
C14.280.484
|
Concept/Terms |
Heart Valve Diseases- Heart Valve Diseases
- Disease, Heart Valve
- Diseases, Heart Valve
- Heart Valve Disease
- Valve Disease, Heart
- Valve Diseases, Heart
- Valvular Heart Diseases
- Disease, Valvular Heart
- Diseases, Valvular Heart
- Heart Disease, Valvular
- Heart Diseases, Valvular
- Valvular Heart Disease
|
Below are MeSH descriptors whose meaning is more general than "Heart Valve Diseases".
Below are MeSH descriptors whose meaning is more specific than "Heart Valve Diseases".
This graph shows the total number of publications written about "Heart Valve Diseases" by people in this website by year, and whether "Heart Valve Diseases" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 2 | 2 | 4 |
1997 | 3 | 5 | 8 |
1998 | 6 | 4 | 10 |
1999 | 2 | 3 | 5 |
2000 | 1 | 4 | 5 |
2001 | 2 | 4 | 6 |
2002 | 4 | 2 | 6 |
2003 | 6 | 1 | 7 |
2004 | 4 | 2 | 6 |
2005 | 6 | 6 | 12 |
2006 | 3 | 0 | 3 |
2007 | 10 | 4 | 14 |
2008 | 9 | 1 | 10 |
2009 | 10 | 5 | 15 |
2010 | 8 | 3 | 11 |
2011 | 16 | 4 | 20 |
2012 | 14 | 1 | 15 |
2013 | 23 | 3 | 26 |
2014 | 20 | 6 | 26 |
2015 | 39 | 3 | 42 |
2016 | 20 | 6 | 26 |
2017 | 22 | 1 | 23 |
2018 | 24 | 2 | 26 |
2019 | 28 | 1 | 29 |
2020 | 27 | 5 | 32 |
2021 | 9 | 2 | 11 |
2022 | 18 | 2 | 20 |
2023 | 11 | 0 | 11 |
2024 | 4 | 2 | 6 |
Below are the most recent publications written about "Heart Valve Diseases" by people in Profiles.
-
Impact of Balloon-Expandable TAVR Valve Deformation and Calcium Distribution on Outcomes in Bicuspid Aortic Valve. JACC Cardiovasc Interv. 2024 Sep 09; 17(17):2023-2037.
-
The Association of Mitral Annular Calcification With Cardiovascular and Noncardiovascular Outcomes: The Multi-Ethnic Study of Atherosclerosis. Am J Cardiol. 2024 Aug 15; 225:75-83.
-
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1652-1663.
-
Valvular Heart Disease in Pregnancy. Methodist Debakey Cardiovasc J. 2024; 20(2):13-23.
-
Lymphangiogenesis in Rheumatic Heart Valve Disease: A New Factor in the Pathogenic Conundrum. Arterioscler Thromb Vasc Biol. 2024 04; 44(4):822-825.
-
Implications of Mitral Annular Calcification on Outcomes Following Mitral Transcatheter Edge-to-Edge Repair. Circ Cardiovasc Interv. 2024 02; 17(2):e013424.
-
Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. Circulation. 2024 01 30; 149(5):391-401.
-
Diagnosis, Classification, and Management Strategies for Mitral Annular Calcification: A Heart Valve Collaboratory Position Statement. JACC Cardiovasc Interv. 2023 09 25; 16(18):2195-2210.
-
5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results. JACC Cardiovasc Interv. 2023 09 25; 16(18):2211-2227.
-
No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response. J Vet Intern Med. 2023 Nov-Dec; 37(6):2145-2156.